chronic obstructive lungdisease COPD
Conditions
Interventions
Group 1 will be treated with PESF for 30 minutes in 3 consecutive sessions, in
a working week. Group 2 will undergo 3 sham sessions of 30 minutes in the same
way. After a "wash-out" period of 30 day
Sponsors
OLVG
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: - 40-85 years old - Male and female - COPD patients, postbronchodilator FEV1/FVC
Exclusion criteria
Exclusion criteria: - Known malignant condition with limited life expactancy - Carrier of electrical equipment (pacemaker, ICD etc.) - COPD exacerbation in the last 3 weeks - Participation in other research - Woman who are pregnant, breastfeeding or of childbearing age without effective contraception unless they meet the postmenopausal definition: 12 months of natural omenorrhea or 6 months of spontaneous ammenorrhea with serum FSH>40 mIU/mL or the use of one or more of the following acceptable methods of birth control: a) surgical sterilication, b) hormonal contraception c) barrier methods: condom or occlusion cap with spermicide d) constant abstention. - Manifest acute inflammation - Patients with manifest decompensatio cordis - Rehabilitation/reactivation programs within 2 months before or during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary study parameter is distance measured in 6MWT immediately after the first treatment and cumulatively after 3 consecutive treatments with PESF. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Quality of life (CCQ) and BORG score as measured in 6MWT - Oxygen saturation during and up to 24hours after the PESF/ Sham treatment - spirometry and diffusion - phase angle | — |
Countries
Netherlands
Outcome results
None listed